Treatment of Metastatic Colorectal Cancer: Beyond Progression
<p id="p1">Metastatic colorectal cancer is a major health problem, accounting for 8.1% of US cancer cases. Although 5-FU-oxaliplatin-irinotecan-based chemotherapy combination regimens and targeted therapies have increased 5-year survival rates to around 13%. The still low rate of this rate increases...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1175908 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!